Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Catheter-based coronary interventions: stents

Citations 541-550 of 991 total displayed.

Past content (since Jan 1999):

Clinical Investigations and Reports
Five-Year Follow-Up After Intracoronary Gamma Radiation Therapy for In-Stent Restenosis
Ron Waksman, Andrew E. Ajani, R. Lawrence White, Rosanna Chan, Bill Bass, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Rebecca Torguson, Regina Deible, Ellen Pinnow, and Joseph Lindsay
Circulation 2004;109:340-344; published online before print as doi:10.1161/01.CIR.0000109488.62415.01 [Abstract] [Full text]  

Articles
High Plasma Heparin Cofactor II Activity Is Associated With Reduced Incidence of In-Stent Restenosis After Percutaneous Coronary Intervention
Nobuyuki Takamori, Hiroyuki Azuma, Midori Kato, Shunji Hashizume, Ken-ichi Aihara, Masashi Akaike, Katsuya Tamura, and Toshio Matsumoto
Circulation published January 26, 2004, doi:10.1161/01.CIR.0000109695.39671.37 [Abstract]  

Articles
Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary Stent. The European evaLUation of pacliTaxel Eluting Stent (ELUTES) Trial
Anthony Gershlick, Ivan De Scheerder, Bernard Chevalier, Amanda Stephens-Lloyd, Edoardo Camenzind, Christian Vrints, Nicolaus Reifart, Luc Missault, Jean-Jacques Goy, Jeffrey A. Brinker, Albert E. Raizner, Philip Urban, and Alan W. Heldman
Circulation published January 26, 2004, doi:10.1161/01.CIR.0000109694.58299.A0 [Abstract]  

Articles
Five-Year Follow-Up After Intracoronary Gamma Radiation Therapy for In-Stent Restenosis
Ron Waksman, Andrew E. Ajani, R. Lawrence White, Rosanna Chan, Bill Bass, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Rebecca Torguson, Regina Deible, Ellen Pinnow, and Joseph Lindsay
Circulation published January 19, 2004, doi:10.1161/01.CIR.0000109488.62415.01 [Abstract]  

Articles
Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the "Real World." The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry
Pedro A. Lemos, Patrick W. Serruys, Ron T. van Domburg, Francesco Saia, Chourmouzios A. Arampatzis, Angela Hoye, Muzaffer Degertekin, Kengo Tanabe, Joost Daemen, Tommy K.K. Liu, Eugene McFadden, Georgios Sianos, Sjoerd H. Hofma, Pieter C. Smits, Willem J. van der Giessen, and Pim J. de Feyter
Circulation published December 22, 2003, doi:10.1161/01.CIR.0000109138.84579.FA [Abstract]  

Articles
Chronic Arterial Responses to Polymer-Controlled Paclitaxel-Eluting Stents. Comparison With Bare Metal Stents by Serial Intravascular Ultrasound Analyses: Data From the Randomized TAXUS-II Trial
Kengo Tanabe, Patrick W. Serruys, Muzaffer Degertekin, Giulio Guagliumi, Eberhard Grube, Charles Chan, Thomas Munzel, Jorge Belardi, Witold Ruzyllo, Luc Bilodeau, Henning Kelbaek, John Ormiston, Keith Dawkins, Louis Roy, Bradley H. Strauss, Clemens Disco, Jörg Koglin, Mary E. Russell, Antonio Colombo for the TAXUS II Study Group
Circulation published December 22, 2003, doi:10.1161/01.CIR.0000109137.51122.49 [Abstract]  

Focused Perspectives
Selecting the Best Reperfusion Strategy in ST-Elevation Myocardial Infarction: It’s All a Matter of Time
Robert P. Giugliano and Eugene Braunwald
Circulation 2003;108:2828-2830, doi:10.1161/01.CIR.0000106684.71725.98 [Full text]  

Focused Perspectives
Are Stenting and Glycoprotein IIb/IIIa Blockade of Good Value in Primary Percutaneous Coronary Intervention?
Jason H. Cole and William S. Weintraub
Circulation 2003;108:2831-2833, doi:10.1161/01.CIR.0000106681.88891.F2 [Full text]  

Clinical Investigations and Reports
Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial
Philippe Gabriel Steg, Eric Bonnefoy, Sylvie Chabaud, Frédéric Lapostolle, Pierre-Yves Dubien, Pascal Cristofini, Alain Leizorovicz, Paul Touboul for the Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators
Circulation 2003;108:2851-2856; published online before print as doi:10.1161/01.CIR.0000103122.10021.F2 [Abstract] [Full text]  

Clinical Investigations and Reports
Cost-Effectiveness of Coronary Stenting and Abciximab for Patients With Acute Myocardial Infarction: Results From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial
Ameet Bakhai, Gregg W. Stone, Cindy L. Grines, Sabina A. Murphy, Louise Githiora, Ronna H. Berezin, David A. Cox, Thomas Stuckey, John J. Griffin, James E. Tcheng, David J. Cohen for the CADILLAC Investigators
Circulation 2003;108:2857-2863; published online before print as doi:10.1161/01.CIR.0000103121.26241.FA [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100

* Subspecialty Collections Home

* Show  Catheter-based coronary interventions: stents
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment